Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.800
+0.020 (1.12%)
At close: Jul 30, 2026, 4:00 PM EDT
1.780
-0.020 (-1.11%)
After-hours: Jul 30, 2026, 8:00 PM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $9.32 million as of July 30, 2026.
Market Cap
9.32M
Enterprise Value
3.19M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.80
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $9.32M, a decrease of -76.36%. That is a compound annual growth rate of -89.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 9.32M | -73.29% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precision Optics Corporation | 46.63M |
| Nephros | 37.24M |
| Milestone Scientific | 35.44M |
| Harvard Bioscience | 27.02M |
| Retractable Technologies | 20.06M |
| Jin Medical International | 15.65M |
| Bionano Genomics | 12.39M |
| Cuprina Holdings (Cayman) Limited | 9.68M |